Answers are grounded in this paper and cite their sources.
As a less O 2 ‐dependent photodynamic therapy (PDT), type I PDT is an effective approach to overcome the hypoxia‐induced low efficiency against solid tumors. However, the commonly used metal‐involved agents suffer from the long‐term biosafety concern. Herein, a metal‐free type I photosensitizer, N ‐doped carbon dots/mesoporous silica nanoparticles (NCDs/MSN, ≈40 nm) nanohybrid with peroxidase (POD)‐like activity for synergistic PDT and enzyme‐activity treatment, is developed on gram scale via a facile one‐pot strategy through mixing carbon source and silica precursor with the assistance of template. Benefiting from the narrow bandgap (1.92 eV) and good charge separation capacity of NCDs/MSN, upon 640 nm light irradiation, the excited electrons in the conduction band can effectively generate O 2 •− by reduction of dissolved O 2 via a one‐electron transfer process even under hypoxic conditions, inducing apoptosis of tumor cells. Moreover, the photoinduced O 2 •− can partially transform into more toxic • OH through a two‐electron reduction. Moreover, the POD‐like activity of NCDs/MSN can catalyze the endogenous H 2 O 2 to • OH in the tumor microenvironment, further synergistically ablating 4T1 tumor cells. Therefore, a mass production way to synthesize a novel metal‐free type I photosensitizer with enzyme‐mimic activity for synergistic treatment of hypoxic tumors is provided, which exhibits promising clinical translation prospects.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: